Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers
European Journal of Rheumatology, cilt.2, sa.2, ss.62-65, 2015 (ESCI, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 2 Sayı: 2
- Basım Tarihi: 2015
- Doi Numarası: 10.5152/eurjrheum.2015.0101
- Dergi Adı: European Journal of Rheumatology
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.62-65
- Anahtar Kelimeler: Hepatitis B, anti-cyclic citrullinated peptide, rheumatoid factor, rheumatoid arthritis, C VIRUS-INFECTION, CCP ANTIBODIES, ARTHRITIS, CRYOGLOBULINEMIA, AUTOANTIBODIES, CLASSIFICATION, CRITERIA, ABSENCE, DISEASE, SERA
- Bursa Uludağ Üniversitesi Adresli: Evet
Özet
Objective: Rheumatoid factor (RF) positivity that may occur in a number of patients with hepatitis B (HBV) infection poses challenges in terms of differential diagnosis with rheumatoid arthritis (RA). On the other hand, antibodies to cyclic citrullinated peptide (anti-CCP) may prove to be an important marker for differential diagnosis of the two conditions. This study aimed to assess anti-CCP and RF positivity among patients with hepatitis B and rheumatoid arthritis.